Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

E.U. approval for Aranesp

Aug. 29, 2002

EP4 selective agonists for treatment of skeletal disorders reported by Pfizer

Aug. 29, 2002

Orexin receptor antagonists described by Actelion

Aug. 28, 2002

Lantus launch in U.K.

Aug. 28, 2002

Pfizer submits IND for bone growth product

Aug. 28, 2002

Takeda presents SAR studies for TAK-013 and TAK-810

Aug. 28, 2002

Antioxidants AEOL-10113 and AEOL-10150 have protective effects on isolated pancreatic islet cells

Aug. 27, 2002

Ortho Tri-Cyclen Lo receives FDA approval

Aug. 26, 2002

Yamanouchi discontinues YM-175

Aug. 26, 2002

New ACAT inhibitors prepared and tested by Pola researchers

Aug. 26, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...